Skip Ribbon Commands
Skip to main content
Menu
Dr Tay Hui Ming

Dr Tay Hui Ming

MBBS, MMed(Int Med), MRCP(UK), FRCPath(UK)

Consultant

Singapore General Hospital

Specialty: Haematology

Sub-specialties: General Haematology

Conditions Treated by this Doctor:
Acute Lymphocytic Leukemia (ALL), Aplastic Anaemia, Chronic lymphocytic leukemia, Chronic Myelogenous Leukemia (CML), Chronic Myeloid Leukemia (CML), Deep Vein Thrombosis, Deep Vein Thrombosis, essential thrombocythemia, Multiple Myeloma, Myelodysplastic Syndromes, Myelofibrosis, Polycythemia Vera, Pulmonary Embolism, Thalassaemia.

Clinical Appointments

  • Consultant SingHealth Duke-NUS Blood Cancer Centre
  • Consultant Haematology Singapore General HospitalSingapore General Hospital
  • Visiting Consultant Department of Pathology Sengkang General HospitalSengkang General Hospital
  • Consultant National Cancer Centre SingaporeNational Cancer Centre Singapore

Academic Appointments

  • Clinical Lecturer, Yong Loo Lin School of Medicine, NUS

Profile

​Dr Tay Hui Ming graduated with MBBS (Singapore) in 2009 and received Master of Medicine(Internal Medicine) in 2013. She underwent Senior Residency Training in Haematology in Singapore General Hospital from 2013 to 2016. She is currently a Consultant with the Department of Haematology, Singapore General Hospital. She has an interest in Diagnostics, Thrombosis, Transfusion and myeloid malignancies (MPN).

Education

  • ​FRCPath Haematology (UK) 2017
  • MMed Internal Medicine (Singapore) 2012 
  • MRCP (UK) 2012 
  • MBBS National University of Singapore 2009 

Professional Appointments and Committee Memberships

  • ​Visiting Consultant, Blood Services Group, Health Sciences Authority

Awards

  • ​9th APSTH Congress, Taiwan 2016 - Best Poster Award
  • Singhealth Residency 2016 – Outstanding Resident Award

Research Interests

Publications

  • Chua H-R, Wong W-K, Ong VH, Agrawal D, Vathsala A, Tay H-M, et al. Extended Mortality and Chronic Kidney Disease After Septic Acute Kidney Injury. J Intensive Care Med. 2020 Jun;35(6):527–35. 
  • Tay HM, Lai YF, Kong MC, See E, Yeang SH, Koh SK, et al. Generational performance of three point-of-care testing devices compared with standard laboratory measurement of the international normalised ratio across extended ranges. J Clin Pathol. 2019 Apr;72(4):311–5. 
  • de Mel S, Li JB, Abid MB, Tang T, Tay HM, Ting WC, et al. The utility of flow cytometry in differentiating NK/T cell lymphoma from indolent and reactive NK cell proliferations. Cytometry B Clin Cytom. 2018 Jan;94(1):159–68. 
  • Mya HT, Tay HM, Gan SW, Surendran S, Yeang SH, Lim CC, et al. Screening frequency, incidence and pattern of heparin-induced thrombocytopenia syndrome at a large tertiary institution. Int J Hematol. 2016 Jul;104(1):92–8. 

Research Trials